Efficacy and toxicity profile of Lutetium-177-ethylenediamine tetramethylene phosphonate (EDTMP) for bone pain palliation in metastatic prostate and breast cancer: Initial results from clinical trial

被引：0
|
作者：
Agarwal, K. K. [1 ]
Bal, C. [1 ]
Singla, S. [1 ]
Sharma, P. [1 ]
Dhull, V. S. [1 ]
Khangembam, B. C. [1 ]
Zaknun, J. [2 ]
Malhotra, A. [1 ]
机构：
[1] All India Inst Med Sci, New Delhi, India
[2] IAEA, A-1400 Vienna, Austria
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2012年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P0003
引用
收藏
页码：S304 / S304
页数：1
相关论文
共 24 条
  • [1] Lutetium-177-ethylenediamine tetramethylene phosphonate (EDTMP) for bone pain palliation in metastatic prostate and breast cancer: A single institutional experience
    Agarwal, K. K.
    Bal, C.
    Singla, S.
    Malhotra, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S189 - S189
  • [2] Efficacy and toxicity profile of low dose 177 Lutetium-Ethylenediamine tetra methylene phosphonate (177Lu-EDTMP) for bone pain palliation in patients with skeletal metastases
    Halanaik, A. S. A. D.
    Pandit, N.
    Ponnusamy, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S371 - S372
  • [3] 177 Lu-EDTMP for bone pain palliation in metastatic prostate and breast cancer: A phase II trial
    Liu, Xingdang
    Liu, Congjin
    Li, Hongyu
    Xiang, Xueqin
    Luo, Zhifu
    Wang, Yuankai
    Zaknun, John
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [4] 177 Lu-EDTMP for Bone Pain Palliation in Metastatic Prostate and Breast Cancer: a phase II trial
    Liu, X.
    Liu, C.
    Li, H.
    Luo, Z.
    Wang, Y.
    John, Z. J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S225 - S225
  • [5] Comparative therapeutic efficacy and toxicity profile of low dose (35 mCi) versus high dose (70 mCi) 177Lu-EDTMP for bone pain palliation in metastatic prostate and breast cancer: Initial results from a randomized clinical trial
    Agarwal, Krishan K.
    Bal, Chandrasekhar
    Zaknun, John
    Sharma, Punit
    Naswa, Niraj
    Singla, Suhas
    Damle, Nishikant
    Malhotra, Arun
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [6] Efficacy and Safety of 177Lu-EDTMP in Bone Metastatic Pain Palliation in Breast Cancer and Hormone Refractory Prostate Cancer A Phase II Study
    Yuan, Jie
    Liu, Congjin
    Liu, Xingdang
    Wang, Yuankai
    Kuai, Dayu
    Zhang, Guangming
    Zaknun, John J.
    CLINICAL NUCLEAR MEDICINE, 2013, 38 (02) : 88 - 92
  • [7] 177Lu-EDTMP for palliation of pain from bone metastases in patients with prostate and breast cancer: a phase II study
    Krishan Kant Agarwal
    Suhas Singla
    Geetanjali Arora
    Chandrasekhar Bal
    European Journal of Nuclear Medicine and Molecular Imaging, 2015, 42 : 79 - 88
  • [8] 177Lu-EDTMP for palliation of pain from bone metastases in patients with prostate and breast cancer: a phase II study
    Agarwal, Krishan Kant
    Singla, Suhas
    Arora, Geetanjali
    Bal, Chandrasekhar
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 (01) : 79 - 88
  • [9] Efficacy and safety of Lutetium-177 PSMA radioligand therapy versus Docetaxel in metastatic castration resistant prostate cancer - preliminary results of a randomized controlled trial
    Satapathy, Swayamjeet
    Mittal, Bhagwant
    Sood, Ashwani
    Bhattacharya, Anish
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [10] High activity, pain reduction and low toxicity with Lutetium-177 PSMA617 theranostics in metastatic castrate-resistant prostate cancer (mCRPC): results of a phase II prospective trial
    Hofman, Michael
    Violet, John
    Sandhu, Shahneen
    Ferdinandus, Justin
    Thang, Sue Ping
    Iravani, Amir
    Kong, Grace
    Kumar, Aravind Ravi
    Akhurst, Tim
    Jackson, Price
    Scalzo, Mark
    Williams, Scott
    Hicks, Rodney
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
123